As of 10:48 AM EDT. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
106,787.0000
112,250.0000
113,335.0000
118,904.0000
102,100.0000
--
Cost of Revenue
44,290.0000
46,179.0000
52,516.0000
51,252.0000
44,059.0000
--
Gross Profit
62,497.0000
66,071.0000
60,819.0000
67,652.0000
58,041.0000
--
Operating Expense
64,631.0000
64,177.0000
67,985.0000
65,586.0000
57,820.0000
--
Operating Income
-2,134.0000
1,894.0000
-7,166.0000
2,066.0000
221.0000
--
Net Non Operating Interest Income Expense
-3,368.0000
-3,591.0000
-2,548.0000
-1,540.0000
-4,831.0000
--
Other Income Expense
-2,745.0000
-859.0000
535.0000
-666.0000
-2,682.0000
--
Pretax Income
-8,247.0000
-2,556.0000
-9,179.0000
-140.0000
-7,292.0000
--
Tax Provision
484.0000
859.0000
337.0000
148.0000
518.0000
--
Net Income Common Stockholders
-8,731.0000
-3,415.0000
-9,516.0000
-288.0000
-7,810.0000
--
Diluted NI Available to Com Stockholders
-8,731.0000
-3,415.0000
-9,516.0000
-288.0000
-7,810.0000
--
Basic EPS
-0.20
-0.08
-0.23
-0.01
-0.20
--
Diluted EPS
-0.20
-0.08
-0.23
-0.01
-0.20
--
Basic Average Shares
42,740.7500
42,420.0000
41,413.0000
40,343.0000
38,640.0000
--
Diluted Average Shares
42,740.7500
42,420.0000
41,413.0000
40,343.0000
38,640.0000
--
Total Operating Income as Reported
-2,134.0000
1,894.0000
-6,933.0000
2,066.0000
221.0000
--
Total Expenses
108,921.0000
110,356.0000
120,501.0000
116,838.0000
101,879.0000
--
Net Income from Continuing & Discontinued Operation
-8,731.0000
-3,415.0000
-9,516.0000
-288.0000
-7,810.0000
--
Normalized Income
-7,564.6000
-2,915.7200
-9,700.0700
-288.0000
-6,440.5200
--
Interest Expense
3,368.0000
3,591.0000
2,548.0000
1,540.0000
4,831.0000
--
Net Interest Income
-3,368.0000
-3,591.0000
-2,548.0000
-1,540.0000
-4,831.0000
--
EBIT
-4,879.0000
1,035.0000
-6,631.0000
1,400.0000
-2,461.0000
--
EBITDA
2,179.0000
8,033.0000
944.0000
9,021.0000
5,171.0000
--
Reconciled Cost of Revenue
42,702.0000
44,706.0000
51,063.0000
49,471.0000
42,137.0000
--
Reconciled Depreciation
7,058.0000
6,998.0000
7,575.0000
7,621.0000
7,632.0000
--
Net Income from Continuing Operation Net Minority Interest
-8,731.0000
-3,415.0000
-9,516.0000
-288.0000
-7,810.0000
--
Total Unusual Items Excluding Goodwill
-1,944.0000
-632.0000
233.0000
--
-1,876.0000
--
Total Unusual Items
-1,944.0000
-632.0000
233.0000
--
-1,876.0000
--
Normalized EBITDA
4,123.0000
8,665.0000
711.0000
9,021.0000
7,047.0000
--
Tax Rate for Calcs
0.0004
0.0002
0.0002
0.0003
0.0003
--
Tax Effect of Unusual Items
-777.6000
-132.7200
48.9300
--
-506.5200
--
12/31/2019 - 3/19/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NEPH Nephros, Inc.
2.1300
+0.95%
KRMD KORU Medical Systems, Inc.
2.2000
+2.80%
UTMD Utah Medical Products, Inc.
66.84
+0.09%
STXS Stereotaxis, Inc.
1.8650
+0.27%
RVP Retractable Technologies, Inc.
1.1300
-0.88%
AZTA Azenta, Inc.
53.94
+0.06%
QS5.MU Straumann Holding AG
764.80
0.00%
QS50.DU Straumann Holding AG
10.60
-4.50%
LHU.DU LeMaitre Vascular Inc
73.00
0.00%
ANGO AngioDynamics, Inc.
6.00
-2.44%